3-thia-4-arylquinolin-2-one derivatives
US7179920B2 · kind B2 · utility
0Cited by
7References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2004 |
| Grant date | Feb 20, 2007 |
| Priority date | — |
| Expiry date | Jun 25, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/36
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention describes compounds of Formula (I) which are modulators of potassium channels and are useful for treating conditions affected by abnormal potassium channel activity including erectile dysfunction and irritable bowel syndrome
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.